BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal

BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this NIDA-funded study support potential future development of ...

TORM plc - Notice of and Complete Proposals for the Annual General Meeting 2026

Reference is made to TORM plc's (NASDAQ: TRMD) (NASDAQ: TRMD A) company announcement dated 5 March 2026. Please find enclosed formal notice of, and full details of the business to be proposed at, the ...

Bunker Hill Mining Corp.: Bunker Hill Announces Closing of C$33,752,300 Brokered Life Offering, Concurrent Non-Brokered Private Placement and Warrant Exercise

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. KELLOGG, Idaho and VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Minin ...
Goldseiten

Bunker Hill Announces Closing of C$33,752,300 Brokered Life Offering, Concurrent Non-Brokered Private Placement and Warrant Exercise

Bunker Hill Mining Corp. , is pleased to announce that it has closed its previously announced "best efforts" private placement offering of units of the Company. The Company issued 150,808,332 LIFE ...